Genomic profiling of non-small cell lung cancer in the community setting.

e20616Background: Genotyping in patients (pts) with advanced NSCLC may identify mutations (mut) amenable to targeted therapy (TT). We identified in a 2010-2014 community series a 60% testing rate f...